Eastman Chemical Company (EMN)
NYSE: EMN · Real-Time Price · USD
75.11
+2.11 (2.89%)
Aug 19, 2026, 2:18 PM EDT - Market open
Eastman Chemical Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,865 | 8,752 | 9,382 | 9,210 | 10,580 | 10,476 | |
Revenue Growth | -4.53% | -6.71% | 1.87% | -12.95% | 0.99% | 23.64% |
Cost of Revenue | 7,122 | 6,906 | 7,085 | 7,134 | 8,443 | 7,972 |
Gross Profit | 1,743 | 1,846 | 2,297 | 2,076 | 2,137 | 2,504 |
Selling, General & Admin | 627 | 633 | 664 | 768 | 625 | 383 |
Research & Development | 246 | 255 | 250 | 239 | 264 | 254 |
Operating Expenses | 873 | 888 | 914 | 1,007 | 889 | 637 |
Operating Income | 870 | 958 | 1,383 | 1,069 | 1,248 | 1,867 |
Interest Expense | -221 | -219 | -216 | -215 | -182 | -198 |
Interest & Investment Income | 8 | 11 | 16 | - | - | - |
Earnings From Equity Investments | - | -1 | - | 10 | -19 | 16 |
Currency Exchange Gain (Loss) | -6 | -9 | -11 | -11 | 16 | -10 |
Other Non Operating Income (Expenses) | -80 | -74 | -36 | -37 | 3 | 11 |
EBT Excluding Unusual Items | 571 | 666 | 1,136 | 816 | 1,066 | 1,686 |
Merger & Restructuring Charges | -83 | -92 | -58 | -60 | -52 | -48 |
Gain (Loss) on Sale of Assets | - | - | - | 323 | -43 | -552 |
Asset Writedown | -6 | -6 | - | - | - | -3 |
Other Unusual Items | 32 | - | - | - | 6 | -1 |
Pretax Income | 538 | 568 | 1,078 | 1,087 | 977 | 1,082 |
Income Tax Expense | 95 | 93 | 170 | 191 | 181 | 215 |
Earnings From Continuing Operations | 443 | 475 | 908 | 896 | 796 | 867 |
Minority Interest in Earnings | -1 | -1 | -3 | -2 | -3 | -10 |
Net Income | 442 | 474 | 905 | 894 | 793 | 857 |
Net Income to Common | 442 | 474 | 905 | 894 | 793 | 857 |
Net Income Growth | -46.88% | -47.62% | 1.23% | 12.74% | -7.47% | 79.29% |
Shares Outstanding (Basic) | 114 | 115 | 117 | 119 | 124 | 135 |
Shares Outstanding (Diluted) | 115 | 116 | 118 | 119 | 125 | 137 |
Shares Change | -1.58% | -1.95% | -1.26% | -4.40% | -8.90% | 0.44% |
EPS (Basic) | 3.87 | 4.13 | 7.75 | 7.54 | 6.42 | 6.35 |
EPS (Diluted) | 3.83 | 4.10 | 7.67 | 7.49 | 6.35 | 6.25 |
EPS Growth | -46.19% | -46.54% | 2.40% | 17.95% | 1.60% | 78.57% |
Free Cash Flow | 539 | 424 | 688 | 546 | 364 | 1,064 |
Free Cash Flow Per Share | 4.69 | 3.67 | 5.83 | 4.57 | 2.91 | 7.76 |
Dividend Per Share | 3.350 | 3.330 | 3.260 | 3.180 | 3.070 | 2.830 |
Dividend Growth | 1.52% | 2.15% | 2.52% | 3.58% | 8.48% | 5.99% |
Gross Margin | 19.66% | 21.09% | 24.48% | 22.54% | 20.20% | 23.90% |
Operating Margin | 9.81% | 10.95% | 14.74% | 11.61% | 11.80% | 17.82% |
Profit Margin | 4.99% | 5.42% | 9.65% | 9.71% | 7.50% | 8.18% |
Free Cash Flow Margin | 6.08% | 4.84% | 7.33% | 5.93% | 3.44% | 10.16% |
EBITDA | 1,393 | 1,471 | 1,892 | 1,544 | 1,725 | 2,405 |
EBITDA Margin | 15.71% | 16.81% | 20.17% | 16.76% | 16.30% | 22.96% |
D&A For EBITDA | 523 | 513 | 509 | 475 | 477 | 538 |
EBIT | 870 | 958 | 1,383 | 1,069 | 1,248 | 1,867 |
EBIT Margin | 9.81% | 10.95% | 14.74% | 11.61% | 11.80% | 17.82% |
Effective Tax Rate | 17.66% | 16.37% | 15.77% | 17.57% | 18.53% | 19.87% |